Innovating Works

ICMR

ARREST-TB: Accurate Rapid Robust and Economical diagnostic technoliogieS for Tuberculosis INDIAN COUNCIL OF MEDICAL RESEARCHSOCIETY participó en un H2020 H2020-SC1-BHC-2018-2020 This visionary project addresses the key needs of patients, clinicians and the World Health Organisations stated deliverables of affordable,...
2018-12-08 - 2021-06-30 | Financiado
KALADRUG-R: New tools for monitoring drug resistance and treatment response in visceral leishmaniasis in the Ind... INDIAN COUNCIL OF MEDICAL RESEARCHSOCIETY participó en un FP7 Visceral leishmaniasis (VL), one of the most-neglected infectious diseases, has an annual incidence of 500,000 cases. Early treatment is a m...
Financiado
RAPSODI: PRe clinicAl studies of a PSA based human vaccine candidate targeting visceral cutaneOus and mucocu... INDIAN COUNCIL OF MEDICAL RESEARCHSOCIETY participó en un FP7 The global aim of RAPSODI is : · to develop a human vaccine candidate against most or all Leishmania species that cause the most severe leis...
Financiado
LEISHDNAVAX: Development of a DNA vaccine for visceral leishmaniasis INDIAN COUNCIL OF MEDICAL RESEARCHSOCIETY participó en un FP7 This project will focus on the preclinical development of a DNA vaccine for human visceral leishmaniasis. The project is based upon the DNA...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.